falsefalse

Advancing Treatments for Bladder Cancer: Insights from ASCO GU 2024 - Episode 5

Emerging Data in Metastatic Urothelial Carcinoma

, , ,

Neeraj Agarwal, MD, FASCO, provides a comprehensive overview of recent data in metastatic urothelial carcinoma, highlighting the CheckMate 901 and EV-302 studies.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer (MIBC)
    EP. 2: Ongoing Research on Neoadjuvant Therapies in Muscle-Invasive Bladder Cancer
    EP. 3: Recent Updates in Adjuvant Therapy for Muscle-Invasive Bladder Cancer
    EP. 4: Expert Insights on Updates in Adjuvant Therapy for Muscle-Invasive Bladder Cancer
    Now Viewing
    EP. 5: Emerging Data in Metastatic Urothelial Carcinoma
    EP. 6: Clinical Insights on Recent Data in Metastatic Urothelial Carcinoma
    EP. 7: Cisplatin Eligibility and Maintenance Therapy in Metastatic Urothelial Carcinoma
    EP. 8: Later-Line Therapies for Metastatic Urothelial Carcinoma
    EP. 9: Treatment Sequencing Practices in Metastatic Urothelial Carcinoma
    EP. 10: Exciting New Approaches in Metastatic Urothelial Carcinoma
    EP. 11: Key Takeaways on Updates in Bladder Cancer

    Related Content:

    Advancing Treatments for Bladder Cancer: Insights from ASCO GU 2024Fox Chase Cancer CenterHuntsman Cancer Institute at the University of Utah University of North Carolina, Lineberger Comprehensive Cancer CenterFred Hutch Cancer CenterGenitourinary CancersOncLive Peer Exchange®
    Dr Albiges on the Efficacy of Lenvatinib Plus Belzutifan in ccRCC
    Dr Yu on the Evolving Role of AR Inhibitors and Degraders in Metastatic Prostate Cancer
    Fox Chase Cancer Center Study Shows That Examining More Lymph Nodes Was Associated With Improved Outcomes for Patients With Colon Cancer
    x